PATENT CLAIM ANALYSIS

Application Number: 15767822
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "043000"]

Abstract:
Provided are methods and compositions for treating cancers in patients carrying an IDH1 mutation using a combination of an inhibitor of a mutant IDH1 enzyme and a DNA demethylating agent.

Claim (Index 8):
The method of  claim 1 , wherein the dose of COMPOUND 2 is about 50 to 500 mg/day.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 91.0
- Lexical Diversity: 1.24
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15768462', '15368405', '15368439', '15125880', '15949750']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7446607026893025
- 35 USC 102 Novelty (BERT): 0.5908601184505281
- Combined Prediction Score: 0.729280644265425
- Mean Citation Score: 362.585732
- Max Citation Score: 503.23285
- Similarity Product: 415.6025928776085

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test